Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Receivables (2016 - 2025)

Skinvisible's Receivables history spans 15 years, with the latest figure at $5000.0 for Q3 2025.

  • For Q3 2025, Receivables rose 400.0% year-over-year to $5000.0; the TTM value through Sep 2025 reached $5000.0, up 400.0%, while the annual FY2024 figure was $5000.0, 81.2% down from the prior year.
  • Receivables for Q3 2025 was $5000.0 at Skinvisible, roughly flat from $5000.0 in the prior quarter.
  • Across five years, Receivables topped out at $26592.0 in Q4 2023 and bottomed at $82.0 in Q4 2021.
  • The 5-year median for Receivables is $5000.0 (2022), against an average of $6311.6.
  • The largest annual shift saw Receivables crashed 98.94% in 2021 before it skyrocketed 23159.76% in 2022.
  • A 5-year view of Receivables shows it stood at $82.0 in 2021, then surged by 23159.76% to $19073.0 in 2022, then skyrocketed by 39.42% to $26592.0 in 2023, then crashed by 81.2% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Receivables are $5000.0 (Q3 2025), $5000.0 (Q2 2025), and $470.0 (Q1 2025).